A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.
about
A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@en
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@nl
type
label
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@en
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@nl
prefLabel
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@en
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@nl
P2093
P2860
P356
P1476
A randomized, double-blind, pl ...... nse to antidepressant therapy.
@en
P2093
Brooke Geibel
Cynthia Richards
Dan V Iosifescu
Elias Sarkis
James Reynolds
Matthew Dauphin
Rajnish Mago
P2860
P304
P356
10.1177/0269881117722998
P407
P577
2017-08-01T00:00:00Z